InvestorsHub Logo
Followers 10
Posts 594
Boards Moderated 0
Alias Born 02/12/2021

Re: None

Tuesday, 07/19/2022 12:01:25 PM

Tuesday, July 19, 2022 12:01:25 PM

Post# of 44695
From Guiseppe 5 hours ago on another b board.....
at you who
https://www.researchgate.net/publication/361024336_European_Journal_of_Pharmaceutical_and_Medical_Research_243_AVIPTADIL_IN_ACUTE_RESPIRATORY_DISTRESS_SYNDROME_ASSOCIATED_WITH_COVID-19_INFECTION_SJIF_Impact_Factor_6222_EUROPEAN_JOURNAL_OF_PHARMACEUTIC

Conclusion: Use of Aviptadil was safe and effective in improving the
resolution of respiratory failure, shortening the time to recovery, decreasing respiratory distress and preventing
death in respiratory failure patients. The rapidity and magnitude of clinical effect suggests a highly specific role of
Aviptadil in combating the lethal effects of Acute Respiratory Distress Syndrome associated with COVID-19.

My opinion is reflected in my posts, and it is never advice to buy, sell or trade any securities. Do your own due diligence before purchasing anything in the stock market.